EuroMedtech™ 2013 Program Overview

One of the areas of most active and fruitful collaboration within the medtech space has been companion diagnostics. This space has seen players with unique competencies partnering together to create diagnostics that are more effective and personalized than ever before. This panel will explore one such collaboration in depth, bringing together some of the major players of the space to discuss the specifics of formulating and implementing new partnerships.

Moderator:
Tina Tan – Editor, Clinica Medtech Intelligence

• Arne Hengerer – Director Clinical Innovations, Siemens Healthcare
• Claudia Lützeler – Partner, Lützeler Klümper Wachenhausen Rechtsanwälte
• Birgit Reitmaier – Associate Director, Global Business Development and Licensing, Merck KGaA

Share this:

This panel will explore the commercial landscape of medical devices in China, and the benefits, challenges and networks that companies from Europe and the US should be familiar with to operate successfully. The experienced panelists will address issues affecting clinical trials and the regulatory pathways which companies need to negotiate, as well as how to most effectively work with distributors and industry networks, negotiate partnerships, and work with IP.

Moderator:
Sigal Weisswasser – President, EuroMedChina

• Michael Alper – Managing Director, NeuvoMedica
• James Cameron – European Business Development Consultant, GCP ClinPlus
• Ivan Zhai – CEO, GCP ClinPlus

Share this:

The medtech industry has largely been weathering the storm of the global economic downturn for some time now. How has the industry managed to stay on the upswing? Have developments in key areas such as eHealth and diagnostics lived up to the promises of greater efficiency and cost effectiveness demands by cash-strapped healthcare systems? What big innovations, not just in products but in business models, financing and partnering, are responsible for the relative health of the medtech powerhouse? And how can companies small and larger use these new models to develop an edge in a competitive industry?

Moderator:
Regina Hodits – General Partner, Wellington Partners

• Angelo De Rosa – Senior Director, Strategy and Business Development, Europe, Middle East, Africa and Canada, Medtronic
• Benjamin Sarda – Head of Marketing, Orange Healthcare
• Cécile Vienney – CEO, HyPrevention
• Bill Welch – Director, Abbott Ventures, Inc.

Share this:

The development of increasingly sophisticated point-of-care diagnostics has involved similarly increasing levels of collaboration among companies, some well established, others new to the space. How are companies working in partnership to achieve faster, more accurate and more efficient POC results? What new players are involved in these developments? And what will be the next steps in this specialized sector?

Moderator:
Sue Dunkerton – Co-Director, Health KTN

• Jordi Carrera – CEO, STAT-Diagnostica
• Matthew Chandler – Manager, Diagnostics Division, Sagentia
• Alex Clarkson – CEO, Diagnostic Capital
• Mehdi Tavakoli – Technical Director, Health KTN

Share this:

In the development of medical devices, clinicians play key roles, as end users, as key opinion leaders, and often as the source of the innovation itself. For any company, working with clinicians is a key determinant of success. How can companies maximize the benefit of working with clinicians? What are the pivotal points in development where they need to become involved? Join these panelists as they explore the roles clinicians play in the success of innovation.

Moderator:
Ken West – Partner, TCG

• Joerg Breitkopf – Founder and Managing Director, clinicalprojects international GmbH
• Paula Gomes – Global Medical Technology Practice, Cambridge Consultants
• Jon H. Hoem – CEO, Miracor Medical Systems
• Klaus Stoeckemann – Managing Director, Peppermint VenturePartners

Share this:

The regulatory changes in the EU are moving apace, creating a shifting landscape for SMEs and large companies alike. This panel will review recent and upcoming changes in what is a pivotal year for EU medtech regulation. What are the pros and cons of these policy changes for the industry and how will it affect product development in years to come?

Moderator:
Erik Vollebregt – Partner, Axon Partners

• Vicki Anastasi – Senior VP, Medical Devices, Aptiv Solutions
• Steven Bridges – Head of Brussels Office, Rohde Public Policy
• Jochen Eimer – Counsel, WilmerHale

Share this:

Join a group of serial medtech entrepreneurs as they discuss the challenges, failures, successes and rewards of creating companies around innovations in a variety of medtech sectors. Learn key lessons from the medtech trenches from panelists who have negotiated the twists and turns successfully.

Moderator:
Raman Minhas – Director, ATPBio

• Bill Allan – CEO, Vascular Flow
• Catherine Beech OBE – CEO, Oval Medical
• Sameer Kothari – CEO, Zilico

Share this:

One of the oft-suggested means of monetizing eHealth products is the consumer pathway: creating tools that patients themselves can use to diagnose, monitor, and maintain their health and wellbeing, tools that they will pay for. Increasingly, patient groups are also looking at these kinds of tools to empower their members to take control of their own health. Is this a workable business model for eHealth? Can patient group involvement shift current healthcare provision to a greater emphasis on prevention? And how can companies embrace this new dynamic?

Moderator:
Rolf Mathies – Co-Founder and Partner, Earlybird Venture Capital

• Benedikt Aichinger – Head of Sales and Marketing, x-tention
• Marc Molitor – Managing Director, CAPITAL4IP
• Thomas Olesen – Commercial Director Europe, Qualcomm Life

Share this: